Offering Size Sample Clauses

Offering Size. The total offering size has been increased from $500 million to $875 million, which represents an increase of $375 million from the amount reflected in the Preliminary Prospectus Supplement.
Offering Size. The Issuers have increased the aggregate principal amount of the Notes offering from $1.75 billion to $2.2 billion. References in the Preliminary Offering Memorandum to the $1.75 billion aggregate principal amount of notes are hereby amended to reference the issuance of $2.2 billion aggregate principal amount of notes. Similar and corresponding changes will be made wherever applicable to the Preliminary Offering Memorandum, including as discussed below. The last paragraph under the row marked “Ranking” starting on page 7 of the Preliminary Offering Memorandum and each other location where similar language and such amounts may appear in the Preliminary Offering Memorandum is replaced in its entirety with the following “As of September 30, 2017, after giving effect to the offering of the notes, the 7-Eleven Transaction and the use of proceeds therefrom as described under “Use of Proceeds,” we would have had approximately $2.5 billion of debt outstanding, including $119 million of secured indebtedness under our Revolving Credit Facility (excluding approximately $9.0 million of letters of credit outstanding thereunder), and we would have had approximately $1.4 billion of remaining borrowing capacity under our Credit Agreement.” The second sentence under the row marked “Use of Proceeds” on page 9 is amended to read as follows: “We intend to use the net proceeds from this offering to redeem in full all outstanding Existing Senior Notes. The proceeds from the 7-Eleven Transaction will be used to (i) repay in full and terminate the Existing Term Loan, (ii) repay a portion of the outstanding borrowings under the Revolving Credit Facility, (iii) pay all closing costs and taxes in connection with the 7-Eleven Transaction, (iv) redeem all of our outstanding Series A Preferred Units, and (v) fund the repurchase of a portion of our outstanding common units.” The last paragraph under the row marked “Use of Proceeds” on page 9 is deleted in its entirety.
Offering Size. The Company has increased the offering of the Notes from $600 million aggregate principal amount to $750 million aggregate principal amount. Corresponding changes will be made wherever applicable to the Preliminary Prospectus Supplement, including as discussed below.
Offering Size. Up to US$75,150,000 (with a minimum offering of 9,000,000 Subscription Receipts for aggregate gross proceeds to the Company of US$40,050,000).
Offering Size. Disclosures set forth throughout the preliminary prospectus supplement are updated to reflect the increase in the size of the offering from an aggregate principal amount of Notes of $300,000,000 to $500,000,000. All figures presented as giving effect to the offering, including net proceeds from the offering and as adjusted cash and cash equivalents, total debt and total capitalization, excluding unamortized discount and premium, are increased accordingly to give effect to the increase in the offering size. ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM. America Management Companies, LLC AMG-▇▇▇▇▇▇▇▇, LLC AMG-Hillside, LLC AMG-▇▇▇▇▇▇▇▇▇▇, LLC AMG-▇▇▇▇▇, LLC AMG-Southern Tennessee, LLC AMG-Trinity, LLC Andalusia Physician Practices, LLC Ashland Physician Services, LLC Ashley Valley Medical Center, LLC Ashley Valley Physician Practice, LLC Athens Physicians Practice, LLC Athens Regional Medical Center, LLC Athens Surgery Center Partner, LLC ▇▇▇▇ ▇▇, LLC ▇▇▇▇ Physician Practices, Inc. Bolivar Physician Practices, LLC Bourbon Community Hospital, LLC Bourbon Physician Practice, LLC Brim Hospitals, Inc. Buffalo Trace Radiation Oncology Associates, LLC Care Health Company, Inc. Castleview Hospital, LLC Castleview Medical, LLC Castleview Physician Practice, LLC ▇▇▇▇▇ Regional Physician Practices, LLC Clinch Professional Physician Services, LLC Clinch Valley Physicians Associates, LLC Clinch Valley Medical Center, Inc. Clinch Valley Pulmonology, LLC Clinch Valley Urology, LLC Colorado Plains Physician Practices, LLC Community Hospital of Andalusia, Inc. Community Medical, LLC Community-Based Services, LLC ▇▇▇▇▇▇▇▇ Hospital, LLC ▇▇▇▇▇▇▇▇ PHO, LLC Danville Diagnostic Imaging Center, LLC Danville Physician Practices, LLC Danville Regional Medical Center School of Health Professions, LLC Danville Regional Medical Center, LLC DLP Partner, LLC DLP Partner Marquette, LLC DLP Partner MedWest, LLC DLP Partner Twin County, LLC Dodge City Healthcare Group, LLC Dodge City Healthcare Partner, Inc. Fauquier Partner, LLC Georgetown Community Hospital, LLC Georgetown Rehabilitation, LLC HCK ▇▇▇▇▇ Memorial, LLC HDP Andalusia, LLC HDP Georgetown, LLC Hillside Hospital, LLC Historic LifePoint Hospitals, Inc. HRMC, LLC HSCGP, LLC HSC Manager, LLC HST Physician Practic...
Offering Size. (a) The gross proceeds sought to be raised by the Corporation from the Rights Offering, assuming the exercise in full of the Rights, will be equal (as nearly as reasonably practicable) to $10,000,000 (the "Offering Size"). (b) The aggregate number of Rights Units (as nearly as practicable) which are issuable will be determined by dividing the Offering Size by the Subscription Price, as determined at the date of filing the Rights Offering Documents (the "Aggregate Rights Units"), with each holder of Shares at the Record Date receiving one Right per Share. Each Right shall entitle the holder thereof to subscribe for the number of Rights Units equal to the Aggregate Rights Units divided by the number of Shares outstanding on the date of filing the Rights Offering Documents, rounded to three decimal places (the "Rights Offering Ratio"), provided that if any Shares are issued prior to the Record Date (where such Shares are not already included in the determination of the Rights Offering Ratio), the Rights Offering Ratio will remain fixed as determined in the Rights Offering Documents and consequently, the number of Rights issued and the Aggregate Rights Units will be increased.
Offering Size. The Issuer has increased the offering of the Notes from $325 million aggregate principal amount (or $375 million if the over-allotment option to purchase additional Notes is exercised in full) to $350 million aggregate principal amount (or $400 million if the over-allotment option to purchase additional Notes is exercised in full). Corresponding changes will be made wherever applicable in the Preliminary Offering Memorandum, including as discussed below. In particular, at December 31, 2012, on an as adjusted basis after giving effect to this offering, we would have had, on a consolidated basis, approximately $1,578.7 million of outstanding liabilities (or $1,628.9 million if the initial purchaser exercises its over-allotment option in full) (which amounts, with respect to the notes offered hereby and our $300.0 million 2.50% Convertible Notes, reflect the face amount of such notes). In addition, we would have had, on a consolidated basis, up to $100.0 million available under the revolving financing facility of Variable Funding Notes. Substantially all of our liabilities (other than the 2.50% Convertible Notes and the notes offered hereby) are obligations of our subsidiaries, including the Senior Secured Notes, the Variable Funding Notes and the Ecko Note. The notes will be structurally subordinated to all such existing and future indebtedness and other liabilities of our subsidiaries. The “Capitalization” section on pages 37-38 of the Preliminary Offering Memorandum is hereby replaced in its entirety with the “Capitalization” section set forth below: The following table sets forth our consolidated cash and cash equivalents and capitalization as of December 31, 2012: • on an actual basis; and • on an as adjusted basis to reflect the issuance and sale of notes and the application of the net proceeds therefrom to pay the $23.1 million net cost of the convertible note hedge transaction and warrant transaction and to repurchase approximately 2.96 million shares of our common stock concurrently with this offering in privately negotiated transactions effected through Barclays Capital Inc. for an aggregate purchase price of approximately $69.0 million (the price per share of the common stock repurchased in such transactions is equal to the last reported sale price of our common stock on the NASDAQ Global Market on March 12, 2013, which equals $23.29 per share of our common stock). This table should be read in conjunction with “Use of Proceeds” and our consolidated...
Offering Size. The aggregate principal amount of Notes in the offering has been increased to $350,000,000, which represents an increase of $50,000,000 from the amounts reflected in the Preliminary Prospectus Supplement. As a result, all information (including financial information) presented in the Preliminary Prospectus Supplement is deemed to have changed to the extent affected by the changes described herein.
Offering Size. The Issuers have increased the aggregate principal amount of the offering from $250.0 million to $300.0 million. References in the Preliminary Offering Memorandum to the $250.0 million aggregate principal amount of new notes are hereby amended to reference the issuance of $300.0 million aggregate principal amount of new notes. The net proceeds from the increased amount of the offering will be used to repay additional amounts of existing indebtedness outstanding under our Credit Facility. *A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system. In connection with offers and sales of Securities outside the United States: